A great day today. Hope to see more gains.
The annual report did foreshadow a year of unspectacular slog: complete Zeiss product, build CellLIVE units to order. These two are supposed to be self funded but will occupy all existing resources. Then maybe, and only as funds permit, recruit development managers to map out a way back into GI and other fields.
If Optiscan can execute this foundation work without requiring a million in new capital each year that would be just what the doctor ordered and the options granted at the last fund raising @ 10c in 2017 should be in the money.
I'm all for a period of solid, sound foundation laying.
Ann: CellLIVE Update, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.015(7.50%) |
Mkt cap ! $179.5M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 22.0¢ | 20.0¢ | $67.20K | 322.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 45149 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 26834 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| OIL (ASX) Chart |